Search Results 8941-8950 of 34013 for oral

  1. Robotic surgery - Doctors & Departments - Mayo Clinic

    ... Oral and throat cancer, Adenocarcinoma, Laryngeal cancer, Carotid body tumor, Tongue base cancer, Mouth tumor, Salivary gland cancer, Parotid cancer ...

  2. Treatment of recurrent CDI: Examining the efficacy and safety of standardized live biotherapeutics as microbiota restoration therapies - Mayo Clinic

    Feuerstadt P, et al. SER-109, an oral microbiome therapy for recurrent Clostridioides difficile infection. New England Journal of Medicine. 2022;386:220. Refer ...

  3. Thyroid cancer - Doctors and departments - Mayo Clinic

    ... Oral and thro...at cancer, Thyroid cancer, Head and neck cancer, Skull base tumor, Salivary gland tumor, Nasopharyngeal carcinoma, Laryngeal cancer ...

  4. Updates in interstitial lung disease: Current facets of anti-fibrotic therapy - Mayo Clinic

    Current medical management involves two oral anti-fibrotic agents: nintedanib and pirfenidone. Nintedanib is a triple tyrosine kinase inhibitor acting at ...

  5. Publications - Timothy D. Malouff, M.D. - Mayo Clinic

    Oral Oncol. 2025 Nov; 170:107647 Epub 2025 Oct 02. View PubMed; Sabharwal Kennedy, Lin Anna, Cook Katie, Malouff Tim, Ko Stephen, May Byron, Tolaymat Leila ...

  6. Minimally invasive surgery - Doctors & Departments - Mayo Clinic

    ... Oral and throat cancer, Adenocarcinoma, Tongue base cancer, Oropharyngeal cancer. Show more areas of focus for Eric J. Moore, M.D.. Adyr A ...

  7. Thyroid cancer - Doctors and departments - Mayo Clinic

    ... Oral and throat cancer, Adenocarcinoma, Laryngeal cancer, Carotid body tumor, Tongue base cancer, Mouth tumor, Salivary gland cancer, Parotid cancer ...

  8. Phase III Study to Evaluate the Efficacy and Safety of the INTERCEPT Blood System for Red Blood Cells in Patients Undergoing Complex Cardiac Surgery Procedures - Mayo Clinic

    implants, injectables, combined oral contraceptives, some intrauterine devices (IUDs), sexual abstinence or vasectomized partner 6. Signed and dated ...

  9. Clinical trials - Oncology (Medical)

    Patients randomized to GDC-0199+R will be given GDC-0199 daily (oral, target dose 400 mg) and will receive 6 cycles of rituximab infused intravenously (IV) ...

  10. Surgery - Doctors - Mayo Clinic

    ... Oral and throat cancer, Adenocarcinoma, Tongue base cancer, Oropharyngeal cancer. Show more areas of focus for Eric J. Moore, M.D. ...